ReviewThe FEBS journal2021

Expanded access: opening doors to personalized medicine for rare disease patients and patients with neurodegenerative diseases.

P Hande ÖzdinlerPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.